Anika Therapeutics' "ELEVESS Light" receives European CE Mark approval

Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (“HA”) technology, today announced that it has received European CE Mark approval for “ELEVESS^™ Light,” the Company’s latest aesthetic product used for the treatment of fine lines and facial wrinkles. ELEVESS Light will be distributed in the European market by the Company’s current aesthetic dermatology distributors.

“This approval expands our aesthetic dermatology product family and paves the way for an early 2010 launch of ‘ELEVESS Light’ in the European Union and other geographies that provide approvals based on the CE mark,” said Charles H. Sherwood, Ph.D., Anika’s President and Chief Executive Officer. “Domestically, we are in discussions with the FDA about the pathway for approval for this new fine-line product.”